Những hướng đi mới trong điều trị bệnh tim mạch đi kèm ở bệnh phổi tắc nghẽn mãn tính

Australia, T.L.F., 2017, COPD: The Statistics

Xiong, 2017, Can we predict the prognosis of COPD with a routine blood test?, Int. J. Chron. Obstruct. Pulmon. Dis., 12, 615, 10.2147/COPD.S124041

WHO, 2018, The Top 10 Causes of Death

Drost, 2005, Oxidative stress and airway inflammation in severe exacerbations of COPD, Thorax, 60, 293, 10.1136/thx.2004.027946

Thomsen, 2013, Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease, JAMA, 309, 2353, 10.1001/jama.2013.5732

Guarascio, 2013, The clinical and economic burden of chronic obstructive pulmonary disease in the USA, Clinicoecon Outcomes Res., 5, 235

European Respiratory Society, 2011, The economic burden of lung disease, European Lung Whitebook

Vogelmeier, 2017, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary, Am. J. Respir. Crit. Care Med., 195, 557, 10.1164/rccm.201701-0218PP

Bathoorn, 2008, Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations, COPD, 5, 282, 10.1080/15412550802363360

Curkendall, 2006, Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients, Ann. Epidemiol., 16, 63, 10.1016/j.annepidem.2005.04.008

Magnussen, 2014, Withdrawal of inhaled glucocorticoids and exacerbations of COPD, N. Engl. J. Med., 371, 1285, 10.1056/NEJMoa1407154

Peinado, 1998, Endothelial dysfunction in pulmonary arteries of patients with mild COPD, Am. J. Physiol. Lung Cell. Mol. Physiol., 274, L908, 10.1152/ajplung.1998.274.6.L908

Perera, 2007, Inflammatory changes, recovery and recurrence at COPD exacerbation, Eur. Respir. J., 29, 527, 10.1183/09031936.00092506

Vlahos, 2014, Recent advances in pre-clinical mouse models of COPD, Clin. Sci., 126, 253, 10.1042/CS20130182

Vignola, 2004, Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD, Eur. Respir. J., 24, 910, 10.1183/09031936.04.00032603

Barnes, 2016, Inflammatory mechanisms in patients with chronic obstructive pulmonary disease, J. Allergy Clin. Immunol., 138, 16, 10.1016/j.jaci.2016.05.011

Mackay, 2013, COPD exacerbations: causes, prevention, and treatment, Immunol. Allergy Clin. North Am., 33, 95, 10.1016/j.iac.2012.10.006

Donaldson, 2006, COPD exacerbations. 1: Epidemiology, Thorax, 61, 164, 10.1136/thx.2005.041806

MacIntyre, 2008, Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease, Proc. Am. Thorac. Soc., 5, 530, 10.1513/pats.200707-088ET

Lipson, 2018, Once-daily single-inhaler triple versus dual therapy in patients with COPD, N. Engl. J. Med., 378, 1671, 10.1056/NEJMoa1713901

Choi, 2016, Prevalence of bacterial and viral infections in acute exacerbation of chronic obstructive pulmonary disease in single center in South Korea, Am. Thorac. Soc., 193, A5178

Charlson, 2010, Disordered microbial communities in the upper respiratory tract of cigarette smokers, PLoS ONE, 5, e15216, 10.1371/journal.pone.0015216

Sze, 2014, Bacterial microbiome of lungs in COPD, Int. J. Chron. Obstruct. Pulmon. Dis., 9, 229

Hilty, 2010, Disordered microbial communities in asthmatic airways, PLoS ONE, 5, e8578, 10.1371/journal.pone.0008578

Pragman, 2012, The lung microbiome in moderate and severe chronic obstructive pulmonary disease, PLoS ONE, 7, e47305, 10.1371/journal.pone.0047305

Wang, 2018, Resolving viral-induced secondary bacterial infection in COPD: a concise review, Front. Immunol., 9, 2345, 10.3389/fimmu.2018.02345

Celli, 2012, Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 185, 1065, 10.1164/rccm.201110-1792OC

Wouters, 2009, Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?, Proc. Am. Thorac. Soc., 6, 638, 10.1513/pats.200907-073DP

Barnes, 2010, Chronic obstructive pulmonary disease: effects beyond the lungs, PLoS Med., 7, e1000220, 10.1371/journal.pmed.1000220

de Moraes, 2014, Interleukin-6 and interleukin-8 blood levels’ poor association with the severity and clinical profile of ex-smokers with COPD, Int. J. Chron. Obstruct. Pulmon. Dis., 9, 735

Gaki, 2011, Associations between BODE index and systemic inflammatory biomarkers in COPD, J. Chron. Obstruct. Pulmon. Dis., 8, 408, 10.3109/15412555.2011.619599

Hartjes, 2018, Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD, Respirology, 23, 1023, 10.1111/resp.13312

Barnes, 2018, Targeting cytokines to treat asthma and chronic obstructive pulmonary disease, Nat. Rev. Immunol., 18, 454, 10.1038/s41577-018-0006-6

(GOLD), G.I.f.C.O.P.D., 2018, Annual report, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (GOLD)

Sapey, 2011, Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 183, 1176, 10.1164/rccm.201008-1285OC

Stanescu, 1996, Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils, Thorax, 51, 267, 10.1136/thx.51.3.267

O’Donnell, 2004, Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD, Thorax, 59, 837, 10.1136/thx.2003.019349

Vlahos, 2012, Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD, PLoS ONE, 7, e33277, 10.1371/journal.pone.0033277

Barnes, 2009, Role of HDAC2 in the pathophysiology of COPD, Annu. Rev. Physiol., 71, 451, 10.1146/annurev.physiol.010908.163257

George, 2016, Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease, Ther. Adv. Chronic. Dis., 7, 34, 10.1177/2040622315609251

Barnes, 2013, Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease, J. Allergy Clin. Immunol., 131, 636, 10.1016/j.jaci.2012.12.1564

Keatings, 1996, Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma, Am. J. Respir. Crit. Care Med., 153, 530, 10.1164/ajrccm.153.2.8564092

Long, 2018, Precision medicine in COPD: review of mepolizumab for eosinophilic COPD, Breathe (Sheff.), 14, 338, 10.1183/20734735.026318

Brightling, 2005, Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease, Thorax, 60, 193, 10.1136/thx.2004.032516

Brightling, 2000, Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial, Lancet, 356, 1480, 10.1016/S0140-6736(00)02872-5

Leigh, 2006, Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment, Eur. Respir. J., 27, 964, 10.1183/09031936.06.00072105

Pizzichini, 1998, Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis, Am. J. Respir. Crit. Care Med., 158, 1511, 10.1164/ajrccm.158.5.9804028

Bafadhel, 2018, Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials, Lancet Respir. Med., 6, 117, 10.1016/S2213-2600(18)30006-7

Casanova, 2017, Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD, Eur. Respir. J., 50, 1701162, 10.1183/13993003.01162-2017

Yun, 2018, Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease, J. Allergy Clin. Immunol., 141, 2037, 10.1016/j.jaci.2018.04.010

Bafadhel, 2012, Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial, Am. J. Respir. Crit. Care Med., 186, 48, 10.1164/rccm.201108-1553OC

Rahman, 1996, Systemic oxidative stress in asthma, COPD, and smokers, Am. J. Respir. Crit. Care Med., 154, 1055, 10.1164/ajrccm.154.4.8887607

Drost, 2005, Oxidative stress and airway inflammation in severe exacerbations of COPD, Thorax, 60, 293, 10.1136/thx.2004.027946

Austin, 2016, COPD and stroke: are systemic inflammation and oxidative stress the missing links?, Clin. Sci., 130, 1039, 10.1042/CS20160043

Bernardo, 2015, Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities, Pharmacol. Ther., 155, 60, 10.1016/j.pharmthera.2015.08.005

Vlahos, 2014, NADPH oxidases as novel pharmacologic targets against influenza A virus infection, Mol. Pharmacol., 86, 747, 10.1124/mol.114.095216

Passey, 2016, Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease, Pharmacol. Ther., 166, 56, 10.1016/j.pharmthera.2016.06.013

Selemidis, 2008, NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition, Pharmacol. Ther., 120, 254, 10.1016/j.pharmthera.2008.08.005

Drummond, 2011, Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets, Nat. Rev. Drug Discov., 10, 453, 10.1038/nrd3403

Tuder, 2003, Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade, Am. J. Respir. Cell Mol. Biol., 29, 88, 10.1165/rcmb.2002-0228OC

MacNee, 2000, Oxidants/antioxidants and COPD, Chest, 117, 303S, 10.1378/chest.117.5_suppl_1.303S-a

Rahman, 2006, Oxidative stress and redox regulation of lung inflammation in COPD, Eur. Respir. J., 28, 219, 10.1183/09031936.06.00053805

Mak, 2008, Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance [State of the Art Series. Chronic obstructive pulmonary disease in high-and low-income countries. Edited by G. Marks and M. Chan-Yeung. Number 3 in the series], Int. J. Tuberculosis Lung Dis., 12, 368

Duong, 2010, Glutathione peroxidase-1 protects against cigarette smoke-induced lung inflammation in mice, Am. J. Physiol. Lung Cell. Mol. Physiol., 299, L425, 10.1152/ajplung.00038.2010

Vlahos, 2013, Glutathione peroxidase-1 as a novel therapeutic target for COPD, Redox Rep., 18, 142, 10.1179/1351000213Y.0000000053

Avissar, 1996, Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells, Am. J. Physiol. Lung Cell. Mol. Physiol., 270, L173, 10.1152/ajplung.1996.270.2.L173

Nowak, 1996, Increased content of hydrogen peroxide in the expired breath of cigarette smokers, Eur. Respir. J., 9, 652, 10.1183/09031936.96.09040652

Dekhuijzen, 1996, Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 154, 813, 10.1164/ajrccm.154.3.8810624

Lee, 2009, Oxidative stress in COPD and its measurement through exhaled breath condensate, Clin. Transl. Sci., 2, 150, 10.1111/j.1752-8062.2009.00093.x

Rahman, 2000, Oxidative stress and regulation of glutathione in lung inflammation, Eur. Respir. J., 16, 534, 10.1034/j.1399-3003.2000.016003534.x

Yang, 2009, Air pollutants, oxidative stress and human health, Mutat. Res., 674, 45, 10.1016/j.mrgentox.2008.10.005

Huiart, 2005, Cardiovascular morbidity and mortality in COPD, Chest, 128, 2640, 10.1378/chest.128.4.2640

Mullerova, 2013, Cardiovascular comorbidity in COPD systematic literature review, Chest, 144, 1163, 10.1378/chest.12-2847

Sin, 2005, Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality, Proc. Am. Thorac. Soc., 2, 8, 10.1513/pats.200404-032MS

Chatila, 2008, Comorbidities in chronic obstructive pulmonary disease, Proc. Am. Thorac. Soc., 5, 549, 10.1513/pats.200709-148ET

Berger, 2004, Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention, Am. J. Cardiol., 94, 649, 10.1016/j.amjcard.2004.05.034

Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study, JAMA, 272, 1497, 10.1001/jama.1994.03520190043033

Hudson, 1973, Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction, Chest, 63, 661, 10.1378/chest.63.5.661

Gulsvik, 1978, Cardiac arrhythmias in patients with serious pulmonary diseases, Scand. J. Respir. Dis., 59, 154

Mannino, 2008, Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD, Eur. Respir. J., 32, 962, 10.1183/09031936.00012408

Sin, 2006, Mortality in COPD: role of comorbidities, Eur. Respir. J., 28, 1245, 10.1183/09031936.00133805

Maclay, 2009, Vascular dysfunction in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 180, 513, 10.1164/rccm.200903-0414OC

Dirksen, 2003, Outcome measures in chronic obstructive pulmonary disease (COPD), Thorax, 58, 1007, 10.1136/thorax.58.12.1007

Bäck, 2008, Atherosclerosis, COPD and chronic inflammation, Respir. Med., 4, 60

Domenech, 2018, High risk of subclinical atherosclerosis in COPD exacerbator phenotype, Respir. Med., 141, 165, 10.1016/j.rmed.2018.07.004

Husain, 2015, Inflammation, oxidative stress and renin angiotensin system in atherosclerosis, World J. Biol. Chem., 6, 209, 10.4331/wjbc.v6.i3.209

Banerjee, 2017, Stroke caused by atherosclerosis of the major intracranial arteries, Circ. Res., 120, 502, 10.1161/CIRCRESAHA.116.308441

Maclay, 2011, Increased platelet activation in patients with stable and acute exacerbation of COPD, Thorax, 66, 769, 10.1136/thx.2010.157529

Wedzicha, 2000, Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels, Thromb. Haemost., 84, 210, 10.1055/s-0037-1613998

Lahousse, 2013, Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study, Am. J. Respir. Crit. Care Med., 187, 58, 10.1164/rccm.201206-1046OC

Suwa, 2002, Particulate air pollution induces progression of atherosclerosis, J. Am. Coll. Cardiol., 39, 935, 10.1016/S0735-1097(02)01715-1

Ridker, 2011, Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS), Am. Heart J., 162, 597, 10.1016/j.ahj.2011.06.012

Faraci, 2011, Protecting against vascular disease in brain, Am. J. Physiol. Heart Circ. Physiol., 300, H1566, 10.1152/ajpheart.01310.2010

Basuroy, 2009, Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells, Am. J. Physiol. Cell Physiol., 296, C422, 10.1152/ajpcell.00381.2008

Taraseviciene-Stewart, 2006, Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease?, Proc. Am. Thorac. Soc., 3, 687, 10.1513/pats.200605-105SF

Chaouat, 2005, Severe pulmonary hypertension and chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med., 172, 189, 10.1164/rccm.200401-006OC

Lam, 2009, Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study, J. Am. Coll. Cardiol., 53, 1119, 10.1016/j.jacc.2008.11.051

Ball, 2014, Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α, Am. J. Respir. Crit. Care Med., 189, 314, 10.1164/rccm.201302-0302OC

Weir-McCall, 2015, The role of pulmonary arterial stiffness in COPD, Respir. Med., 109, 1381, 10.1016/j.rmed.2015.06.005

Hilde, 2013, Haemodynamic responses to exercise in patients with COPD, Eur. Respir. J., 41, 1031, 10.1183/09031936.00085612

Weitzenblum, 2003, Chronic cor pulmonale, Heart, 89, 225, 10.1136/heart.89.2.225

Skelly, 2006, Risk factors for restenosis after carotid artery angioplasty and stenting, J. Vasc. Surg., 44, 1010, 10.1016/j.jvs.2006.07.039

Bursi, 2010, Chronic obstructive pulmonary disease after myocardial infarction in the community, Am. Heart J., 160, 95, 10.1016/j.ahj.2010.05.004

Santos, 2002, Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD, Eur. Respir. J., 19, 632, 10.1183/09031936.02.00245902

Wright, 1992, Analysis of the structure of the muscular pulmonary arteries in patients with pulmonary hypertension and COPD: National Institutes of Health nocturnal oxygen therapy trial, Lung, 170, 109, 10.1007/BF00175982

Wilkinson, 1988, A pathophysiological study of 10 cases of hypoxic cor pulmonale, Q. J. Med., 66, 65

Friedman, 1976, Lung function and risk of myocardial infarction and sudden cardiac death, N. Engl. J. Med., 294, 1071, 10.1056/NEJM197605132942001

Cook, 1988, Breathlessness, lung function and the risk of heart attack, Eur. Heart J., 9, 1215, 10.1093/oxfordjournals.eurheartj.a062432

Lange, 1991, Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction, Eur. Respir. J., 4, 1080, 10.1183/09031936.93.04091080

Zhang, 2018, Influence of lung function and sleep-disordered breathing on stroke: a community-based study, Eur. J. Neurol., 25, 1307, 10.1111/ene.13722

Truelsen, 2001, Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study, Int. J. Epidemiol., 30, 145, 10.1093/ije/30.1.145

Liao, 1999, Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study, Chest, 116, 150, 10.1378/chest.116.1.150

Bhatt, 2013, Chronic obstructive pulmonary disease and cardiovascular disease, Transl. Res., 162, 237, 10.1016/j.trsl.2013.05.001

Sin, 2005, Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality, Proc. Am. Thorac. Soc., 2, 8, 10.1513/pats.200404-032MS

Abe, 2017, The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases, J. Atheroscler. Thromb., 24, 884, 10.5551/jat.RV17009

Semenza, 2014, Hypoxia-inducible factor 1 and cardiovascular disease, Annu. Rev. Physiol., 76, 39, 10.1146/annurev-physiol-021113-170322

Kato, 2000, Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea, Circulation, 102, 2607, 10.1161/01.CIR.102.21.2607

Heiss, 2014, Regulation of eNOS enzyme activity by posttranslational modification, Curr. Pharm. Des., 20, 3503, 10.2174/13816128113196660745

Arunachalam, 2010, SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol, Biochem. Biophys. Res. Commun., 393, 66, 10.1016/j.bbrc.2010.01.080

Rauchhaus, 2000, Plasma cytokine parameters and mortality in patients with chronic heart failure, Circulation, 102, 3060, 10.1161/01.CIR.102.25.3060

Ueland, 2015, Inflammatory cytokines as biomarkers in heart failure, Clin. Chim. Acta, 443, 71, 10.1016/j.cca.2014.09.001

Harten, 2010, Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection, Antioxid. Redox Signal., 12, 459, 10.1089/ars.2009.2870

Ong, 2014, HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore, Cardiovasc. Res., 104, 24, 10.1093/cvr/cvu172

Jain, 2018, Hypoxia inducible factor as a therapeutic target for atherosclerosis, Pharmacol. Ther., 183, 22, 10.1016/j.pharmthera.2017.09.003

Sidney, 2005, COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program, Chest, 128, 2068, 10.1378/chest.128.4.2068

Piepoli, 2016, 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur. Heart J., 252, 207

Maclay, 2013, Cardiovascular disease in COPD: mechanisms, Chest, 143, 798, 10.1378/chest.12-0938

Gudmundsson, 2016, Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study, Atherosclerosis, 252, 122, 10.1016/j.atherosclerosis.2016.07.919

Badimon, 2012, Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease, Eur. Heart J. Acute Cardiovasc. Care, 1, 60, 10.1177/2048872612441582

Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353

Smith, 2014, Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS), Thorax, 69, 987, 10.1136/thoraxjnl-2014-205160

Hill, 2001, Invited review: arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity, J. Appl. Physiol. (1985), 91, 973, 10.1152/jappl.2001.91.2.973

Ismaeel, 2018, Oxidative stress and arterial dysfunction in peripheral artery disease, Antioxidants (Basel), 7, 145, 10.3390/antiox7100145

Li, 2018, Nicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH1, J. Cell. Mol. Med., 22, 5406, 10.1111/jcmm.13812

Engin, 2017, Endothelial dysfunction in obesity, Adv. Exp. Med. Biol., 960, 345, 10.1007/978-3-319-48382-5_15

Harrison, 2011, Mitochondrial oxidative stress significantly influences atherogenic risk and cytokine-induced oxidant production, Environ. Health Perspect., 119, 676, 10.1289/ehp.1002857

Shenouda, 2011, Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus, Circulation, 124, 444, 10.1161/CIRCULATIONAHA.110.014506

Siasos, 2009, The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance, Am. J. Hypertens., 22, 586, 10.1038/ajh.2009.57

Taddei, 2001, Age-related reduction of NO availability and oxidative stress in humans, Hypertension, 38, 274, 10.1161/01.HYP.38.2.274

Zhang, 2006, Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress, Hypertension, 48, 278, 10.1161/01.HYP.0000231509.27406.42

Polverino, 2018, COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series), Pulm. Circ., 8, 2045894018758528, 10.1177/2045894018758528

Jennings, 2009, Role of platelets in atherothrombosis, Am. J. Cardiol., 103, 4A, 10.1016/j.amjcard.2008.11.017

Davie, 1991, The coagulation cascade: initiation, maintenance, and regulation, Biochemistry, 30, 10363, 10.1021/bi00107a001

Biljak, 2011, Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease, Platelets, 22, 466, 10.3109/09537104.2011.573887

Viles-Gonzalez, 2004, Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences, Eur. Heart J., 25, 1197, 10.1016/j.ehj.2004.03.011

Koenig, 2007, Biomarkers of atherosclerotic plaque instability and rupture, Arterioscler. Thromb. Vasc. Biol., 27, 15, 10.1161/01.ATV.0000251503.35795.4f

Fluri, 2017, Platelets and stroke, Platelets, Haemostasis and Inflammation, 253, 10.1007/978-3-319-66224-4_16

Cha, 2004, Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke, Platelets, 15, 3, 10.1080/09537100310001644024

Davi, 2007, Mechanisms of disease: platelet activation and atherothrombosis, N. Engl. J. Med., 357, 2482, 10.1056/NEJMra071014

Milovanovic, 2004, Relationships between platelets and inflammatory markers in rheumatoid arthritis, Clin. Chim. Acta, 343, 237, 10.1016/j.cccn.2003.12.030

Cui, 2012, Clinical value of mean platelet volume for impaired cardiopulmonary function in very old male patients with chronic obstructive pulmonary disease, Arch. Gerontol. Geriatr., 54, E109, 10.1016/j.archger.2011.09.013

Agapakis, 2016, The role of mean platelet volume in chronic obstructive pulmonary disease exacerbation, Respir. Care, 61, 44, 10.4187/respcare.04132

Steiropoulos, 2013, Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities, Angiology, 64, 535, 10.1177/0003319712461436

Malerba, 2013, Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease, Expert Rev. Hematol., 6, 475, 10.1586/17474086.2013.814835

Ishida, 2014, Antiplatelet strategies for secondary prevention of stroke and TIA, Curr. Atheroscler. Rep., 16, 449, 10.1007/s11883-014-0449-6

Harrison, 2014, Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?, Thorax, 69, 609, 10.1136/thoraxjnl-2013-203996

De Silva, 2011, Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke, PLoS ONE, 6, e28393, 10.1371/journal.pone.0028393

Famakin, 2014, The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review, Aging Dis., 5, 307

Oppenheim, 2007, Alarmins initiate host defense, Immune-Mediated Diseases, 185, 10.1007/978-0-387-72005-0_19

Matzinger, 1998, An innate sense of danger, Semin Immunol., 399

Vogelgesang, 2010, Functional status of peripheral blood T-cells in ischemic stroke patients, PLoS ONE, 5, e8718, 10.1371/journal.pone.0008718

Lakhan, 2009, Inflammatory mechanisms in ischemic stroke: therapeutic approaches, J. Transl. Med., 7, 97, 10.1186/1479-5876-7-97

Lambertsen, 2012, Inflammatory cytokines in experimental and human stroke, J. Cereb. Blood Flow Metab., 32, 1677, 10.1038/jcbfm.2012.88

Waje-Andreassen, 2005, IL-6: an early marker for outcome in acute ischemic stroke, Acta Neurol. Scand., 111, 360, 10.1111/j.1600-0404.2005.00416.x

Yamasaki, 1995, Interleukin-1 as a pathogenetic mediator of ischemic brain-damage in rats, Stroke, 26, 676, 10.1161/01.STR.26.4.676

Smith, 2004, Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome, BMC Neurol., 4, 2, 10.1186/1471-2377-4-2

Nawashiro, 1997, TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice, J. Cereb. Blood Flow Metab., 17, 483, 10.1097/00004647-199705000-00001

Ginis, 2002, TNF-α–induced tolerance to ischemic injury involves differential control of NF-κB transactivation: the role of NF-κB association with p300 adaptor, J. Cereb. Blood Flow Metab., 22, 142, 10.1097/00004647-200202000-00002

Pettigrew, 2008, Focal cerebral ischemia in the TNFalpha-transgenic rat, J. Neuroinflammation, 5, 47, 10.1186/1742-2094-5-47

Garcia-Bonilla, 2012, Peroxiredoxin sets the brain on fire after stroke, Nat. Med., 18, 858, 10.1038/nm.2797

Daga, 2003, Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease, J. Biosci., 28, 7, 10.1007/BF02970125

Bernardo, 2018, Targeting NADPH oxidase-2 reduces cigarette smoke-induced lung inflammation and skeletal muscle wasting in mice, Eur. Respir. Soc., 52, OA195, 10.1183/13993003.congress-2018.OA1945

Smith, 2002, Inhibition of tobacco smoke-induced lung inflammation by a catalytic antioxidant, Free Radic. Biol. Med., 33, 1106, 10.1016/S0891-5849(02)01003-1